HIV Testing Uptake and Prevalence Among Adolescents and Adults in a Large Home-based HIV Testing Program in Western Kenya
Overview
Affiliations
Objective: To describe HIV testing uptake and prevalence among adolescents and adults in a home-based HIV counseling and testing program in western Kenya.
Methods: Since 2007, the Academic Model Providing Access to Healthcare program has implemented home-based HIV counseling and testing on a large scale. All individuals aged ≥13 years were eligible for testing. Data from 5 of 8 catchments were included in this analysis. We used descriptive statistics and multivariate logistic regression to examine testing uptake and HIV prevalence among adolescents (13-18 years), younger adults (19-24 years), and older adults (≥25 years).
Results: There were 154,463 individuals eligible for analyses as follows: 22% adolescents, 19% younger adults, and 59% older adults. Overall mean age was 32.8 years and 56% were female. HIV testing was high (96%) across the following 3 groups: 99% in adolescents, 98% in younger adults, and 94% in older adults (P < 0.001). HIV prevalence was higher (11.0%) among older adults compared with younger adults (4.8%) and adolescents (0.8%) (P < 0.001). Those who had ever previously tested for HIV were less likely to accept HIV testing (adjusted odds ratio: 0.06, 95% confidence interval: 0.05 to 0.07) but more likely to newly test HIV positive (adjusted odds ratio: 1.30, 95% confidence interval: 1.21 to 1.40). Age group differences were evident in the sociodemographic and socioeconomic factors associated with testing uptake and HIV prevalence, particularly, gender, relationship status, and HIV testing history.
Conclusions: Sociodemographic and socioeconomic factors were independently associated with HIV testing and prevalence among the age groups. Community-based treatment and prevention strategies will need to consider these factors.
Embleton L, Logie C, Ngure K, Nelson L, Kimbo L, Ayuku D AIDS Behav. 2022; 27(Suppl 1):162-184.
PMID: 35907143 PMC: 10192191. DOI: 10.1007/s10461-022-03793-4.
Wang J, Mugo C, Omondi V, Njuguna I, Maleche-Obimbo E, Inwani I AIDS Behav. 2022; 26(9):3045-3055.
PMID: 35306611 PMC: 9378682. DOI: 10.1007/s10461-022-03643-3.
Shanaube K, Macleod D, Chaila M, Mackworth-Young C, Hoddinott G, Schaap A J Adolesc Health. 2020; 68(4):719-727.
PMID: 33059959 PMC: 8022105. DOI: 10.1016/j.jadohealth.2020.07.029.
Labhardt N, Ringera I, Lejone T, Amstutz A, Klimkait T, Muhairwe J BMC Public Health. 2019; 19(1):1441.
PMID: 31676001 PMC: 6825349. DOI: 10.1186/s12889-019-7784-z.
Akiyama M, Cleland C, Lizcano J, Cherutich P, Kurth A Lancet Infect Dis. 2019; 19(11):1255-1263.
PMID: 31540840 PMC: 7099605. DOI: 10.1016/S1473-3099(19)30264-6.